DrugPatentWatch Database Preview

Deutetrabenazine - Generic Drug Details

« Back to Dashboard

What are the generic sources for deutetrabenazine and what is the scope of freedom to operate?

Deutetrabenazine is the generic ingredient in one branded drug marketed by Teva Branded Pharm and is included in one NDA. There are six patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Deutetrabenazine has seventy-one patent family members in twenty-eight countries.

One supplier is listed for this compound.

Summary for deutetrabenazine

International Patents:	71
US Patents:	6
Tradenames:	1
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	18
Clinical Trials:	14
Patent Applications:	93
Formulation / Manufacturing:	see details
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for deutetrabenazine
What excipients (inactive ingredients) are in deutetrabenazine?	deutetrabenazine excipients list
DailyMed Link:	deutetrabenazine at DailyMed

Recent Clinical Trials for deutetrabenazine

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Vanderbilt University Medical Center	Phase 2/Phase 3
Teva Branded Pharmaceutical Products R&D, Inc.	Phase 2/Phase 3
Fundacion Huntington Puerto Rico	Phase 1

See all deutetrabenazine clinical trials

Paragraph IV (Patent) Challenges for DEUTETRABENAZINE

Tradename	Dosage	Ingredient	NDA	Submissiondate
AUSTEDO	TABLET;ORAL	deutetrabenazine	208082

US Patents and Regulatory Information for deutetrabenazine

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Teva Branded Pharm	AUSTEDO	deutetrabenazine	TABLET;ORAL	208082-001	Apr 3, 2017		RX	Yes	No
Teva Branded Pharm	AUSTEDO	deutetrabenazine	TABLET;ORAL	208082-002	Apr 3, 2017		RX	Yes	No
Teva Branded Pharm	AUSTEDO	deutetrabenazine	TABLET;ORAL	208082-001	Apr 3, 2017		RX	Yes	No
Teva Branded Pharm	AUSTEDO	deutetrabenazine	TABLET;ORAL	208082-002	Apr 3, 2017		RX	Yes	No

International Patents for deutetrabenazine

Country	Patent Number	Estimated Expiration
Poland	3061760
Japan	5970037
Eurasian Patent Organization	201791977
South Africa	201706131